Bulk Pharma Group B

Closed Solicitation Posted

Solicitation number
75A50325R00003
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Georgia 30341, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services' Administration for Strategic Preparedness and Response (ASPR) is seeking to procure a diverse range of FDA-approved pharmaceuticals for the Strategic National Stockpile (SNS). The solicitation covers six specific pharmaceutical products, including Acyclovir Sodium injection, Doxycycline injection, Levophed (Norepinephrine), Meropenem injection, Sodium Chloride injection, and Sterile water for injection. Contractors must be authorized manufacturers, distributors, or resellers with appropriate FDA licenses, and all products must have a minimum of 90% shelf life remaining at delivery. The government intends to award one or more firm-fixed-price contracts based on a best value approach, with technical capabilities and past performance weighted more heavily than price. Key proposal deadlines include January 9, 2025, for submitting questions and January 17, 2025, at 2:00 PM ET for final proposal submission.

The solicitation is an unrestricted competition under NAICS code 325412 with a size standard of 1,300 employees, and there are no specific set-aside designations for small businesses. The contract will include a 12-month base period with four additional 12-month option periods, with deliveries to multiple Strategic National Stockpile locations within the Continental United States. Annual quantities vary significantly by product, ranging from 5,952 units of Doxycycline in the base year to potentially over 1 million bags of Sodium Chloride in later option years. The place of performance is specified as Chamblee, GA 30341, USA. Contractors must provide comprehensive delivery risk mitigation plans and comply with specific requirements for packaging, labeling, shipping, and temperature control during storage and transit of these critical pharmaceutical supplies.

Notice text

This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in Subpart 12.6 of the Federal Acquisition Regulation (FAR), as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

The Center for the Strategic National Stockpile (SNS) of the U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR) is seeking the supply of a diverse range of FDA-approved pharmaceuticals. The Contractor, as an independent organization and not as an agent of the Government, shall furnish all labor, materials, supplies, facilities, equipment, transportation and travel necessary to deliver the acceptable pharmaceuticals. The Contractor shall provide brand name or equal product for the following pharmaceuticals. Quantities are detailed in the Statement of work in the attached Request for Proposal.

Acyclovir Sodium solution for injection, 500mg (50mg/ml) in a 10ml vial

Doxycycline Inj, Powder, Lyophilized 100mg/10ml

Levophed (Norepinephrine) 1mg/ml in 4ml amp

Meropenem for injection, 1g powder vial

Sodium Chloride for inj. 0.9% 250 ml flexi bag

Sterile water for injection, preservative free, 10ml solution vial

Files

Similar open opportunities

Opportunity Agency Set-aside Responses due
Epinephrine Injector NAICS 325412 Medical Supply Chain No set-aside
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity